Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Appropriately aggregate holistic technologies via accurate expertise. Intrinsicly strategize worldwide initiatives and premium methodologies.

Factors, enablers and challenges for COVID-19 vaccine development.

Journal article

Excler J-L. et al, (2023), BMJ global health, 8

Vaccine access, equity and justice: COVID-19 vaccines and vaccination.

Journal article

Privor-Dumm L. et al, (2023), BMJ global health, 8

Adenoviral vectored vaccination protects against Crimean-Congo Haemorrhagic Fever disease in a lethal challenge model

Journal article

Saunders JE. et al, (2023), eBioMedicine, 90, 104523 - 104523

Persistence of the immune response after two doses of ChAdOx1 nCov-19 (AZD1222): 1 year of follow-up of two randomized controlled trials

Journal article

Voysey M. et al, (2023), Clinical and Experimental Immunology, 211, 280 - 287

Booster Vaccination Against SARS-CoV-2 Induces Potent Immune Responses in People With Human Immunodeficiency Virus

Journal article

Fidler S. et al, (2023), Clinical Infectious Diseases, 76, 201 - 209

Lessons from the pandemic: Responding to emerging zoonotic viral diseases-a Keystone Symposia report.

Journal article

Cable J. et al, (2022), Annals of the New York Academy of Sciences

Immunogenicity of High-Dose MVA-Based MERS Vaccine Candidate in Mice and Camels

Journal article

Alharbi NK. et al, (2022), Vaccines, 10

Load More